2 results about "Recombinant interferon" patented technology

This invention discloses a kit for detecting α-interferon and related applications, relating to the biological field. The kit includes a capture protein for capturing α-interferon and a detection protein for detecting α-interferon; the capture protein includes an α-interferon receptor protein; the detection protein includes an antibody against α-interferon. This kit is applied to IFN-α detection, covering multiple IFN-α subtypes, including natural and recombinant interferon, and exhibits no cross-reactivity with INF-β and INF-ε. It has high detection accuracy and good repeatability, enabling rapid and effective detection of IFN-α levels in human serum, thereby more accurately reflecting the overall level and activity status of IFN-α in the body. This is of great significance for understanding human immune status, diagnosing and monitoring disease development, and evaluating the effectiveness of treatment.

The present invention provides methods for treating tumors in subjects by using a recombinant interferon (rSIFN-co), and optionally, methods for treating solid tumors, such as lung cancer, among others, with or without prior surgery, and as a first line or second line monotherapy or in combination with one or more other anti-tumor therapies. The present invention further provides non-surgical methods for eliminating tumors or reducing tumor sizes in subjects, and / or preventing postoperative tumor recurrence and / or metastases in subjects by using the recombinant interferon (rSIFN-co) which comprises a unique spatial configuration, alone or in conjunction with radiotherapy, chemotherapy, and / or one or more anti-tumor drugs such as biological agents, targeted drugs, small molecules, Traditional Chinese Medicine (TCM) and the like.